Veedol Corporation Ltd
VEEDOLVeedol Corporation Ltd's earnings have outrun its stock. EPS grew +13.5% in a year against a −20.0% price move.
The sharpest disagreement: annual EPS moved +13.5% against a −20.0% price move — the market has not yet caught up with the delivery.
The price is in a downtrend (38 weeks in) while the P/E sits at the 3rd percentile of its own 11-year range. Underneath, the last four quarters read improving — profit +56.0% year on year, and 75% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Veedol Corporation Ltd trades at ₹1,429, in a downtrend and 38 weeks into that stage. That is −4.0% against its own 200-day average. It sits at 31% of a 52-week range of ₹1,281 to ₹1,760. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (2 weeks and counting).
Today the stock is in a downtrend — week 38 of stage 4, confirmed. At ₹1,429 it trades −4.0% versus its 200-day average and sits at 31% of its 52-week range (₹1,281–₹1,760).
Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved −1% while the NIFTY 500 moved +267% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (2 weeks and counting; last ahead the week of 2026-08-28) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Veedol Corporation Ltd trades at 11.3× P/E, near the bottom of its own range — cheaper only 3% of the time. Its long-run median P/E is 17.3×, measured across 10.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 11.3× is near the bottom of its own range — cheaper only 3% of the time, against a long-run median of 17.3× measured over 10.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +13.5% against a −20.0% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the −6.4%/yr price move, ~+8.5%/yr came from earnings growth and ~−14.9 pp from the multiple (compressing); over 10y, of the +2.8%/yr price move, ~+9.8%/yr came from earnings growth and ~−7.0 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.
What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.
Solved at its 13 June 2026 price, Veedol Corporation Ltd was paying for profit growth of about 4.5% a year. Profit itself has compounded 8.4% a year over the past 10 years. Today the market pays 11.3× P/E, the 3rd percentile of its own 11-year range.
What the two numbers say together. The multiple is low against its own past, and the growth the price is paying for is close to what this company has actually delivered.
How to hold this number: it is a reading of one day's price, taken on 13 June 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 11 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.
Stage: Consistent Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Veedol Corporation Ltd reads as consistent on its fundamental arc. Consistent — revenue, profit and EPS growth have stayed positive through the window, with ROCE at 23.4% and holding. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: steady curves with healthy returns are the compounding setup — the risk is the price, not the business.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +10.0% | +5.4% | +11.5% | +8.3% |
| Profit | +13.6% | +18.6% | +6.4% | +8.4% |
| EPS | +13.5% | +18.7% | +6.4% | +8.3% |
| Share price | −20.0% | +5.7% | −6.4% | +2.8% |
4-Factor Sector Score
60.4/100 — rank 2 of 4 in Lubricants · 97% evidence confidence
Veedol Corporation Ltd scores 60.4 out of 100 against the 4 companies it is compared with in Lubricants, ranking 2. Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -13.2% and the one-year return is -12.1%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
The four contributions add to the total exactly: 25.7 + 18.9 + 14.7 + 1.1 = 60.4. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Veedol Corporation Ltd reported ₹609 Cr of revenue in the Jun 26 quarter, +18.5% year on year. That is the 6th straight quarter of year-on-year growth. Over 10 years it has compounded at 8.3% a year. The last full year, FY26, came in at ₹2,169 Cr. The last four reported quarters add to ₹2,263 Cr.
FY26 revenue came in at ₹2,169 Cr (+10.0% on the year), capping 10 years at 8.3% compound. The latest quarter (Jun 26) printed ₹609 Cr, +18.5% year on year — the 6th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +12.8% growth against the decade's 8.3% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +12.9% over the last 4 quarters against +8.1%/yr over the last 8 — accelerating; TTM profit +20.9% vs +21.5%/yr — stabilising.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Veedol Corporation Ltd's operating margin is 16.0% in the Jun 26 quarter, +5.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 8.0% to 13.0%. The current quarter is running above every full year in that window.
The latest quarter's operating margin is 16.0%, +5.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 8.0%–13.0%.
Why the margin moved: operating margin went +4.7 pp year on year while gross margin went +2.8 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Veedol Corporation Ltd earned ₹78.0 Cr of net profit in the Jun 26 quarter, +56.0% year on year. Full-year FY26 profit was ₹192 Cr. The 10-year compound rate is 8.4%. That is 12.8% of the quarter's revenue. The same quarter a year earlier earned ₹50.0 Cr.
Jun 26 profit was ₹78.0 Cr, +56.0% year on year. On the full year, FY26 printed ₹192 Cr (+13.6%), and the 10-year compound rate is 8.4%.
Why profit moved: revenue contributed +18.5% and the margin +5.0 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +21.8% vs revenue +12.8%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 75% of Veedol Corporation Ltd's reported profit arrived as operating cash — most of the profit is real cash. In FY26 that was ₹194 Cr of operating cash against ₹192 Cr of profit. After ₹46.0 Cr of capital spending, ₹148 Cr was left as free cash.
FY26: operating cash of ₹194 Cr against reported profit of ₹192 Cr, leaving free cash of ₹148 Cr after ₹46.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 75% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 75%: the cash cycle held roughly steady between FY21 and FY26 — so conversion tracks profitability rather than the cycle.
Router verdict: the bigger cash user is investment — capital spending ran 2.1× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Veedol Corporation Ltd's cash conversion cycle runs 92 days in FY26, up from 90 days in FY21. Capital spending ran ₹163 Cr over the last 3 years. At FY26 sales of ₹2,169 Cr each day of that cycle holds about ₹5.9 Cr, so roughly ₹547 Cr sits inside the business at any moment.
FY26: debtors at 58 days, inventory at 93 days — roughly 3.1 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 92 days, looser than FY21's 90.
The full loop: cash goes out to suppliers and production on day 0; stock waits 93 days to sell; customers pay about 58 days after that; and suppliers themselves are paid at 59 days — netting out to the 92-day cycle.
In money terms: at FY26 sales of ₹2,169 Cr, each day of the cycle holds about ₹5.9 Cr — so the 92-day loop keeps roughly ₹547 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹163 Cr over the last 3 fiscal years against ₹78.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹8.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Veedol Corporation Ltd earns a ROCE of 24% in FY26. That is up from a trough of 18% in FY15. Return on invested capital clears the cost of that capital by +10.3 percentage points, so growth here adds value rather than only size. The wiring behind it is 8.9% net margin on 1.54× asset turns.
FY26 ROCE is 24%, recovered from a FY15 trough of 18% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 8.9% net margin × 1.54× asset turns × 1.36× balance-sheet leverage ≈ 18.6% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
The capstone test — ROIC − WACC: 22.3% − 12.0% = a +10.3 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. A spread this wide means every rupee reinvested creates more than a rupee of value — the engine compounds.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Veedol Corporation Ltd carries total debt of ₹16.0 Cr against shareholder equity of ₹1,036 Cr as of Mar 26, a debt-to-equity of 0.02 — effectively unlevered. On the annual view that ratio went from 0.02 in FY22 to 0.02 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.
Mar 26: total debt of ₹16.0 Cr against shareholder equity of ₹1,036 Cr — a debt-to-equity of 0.02. On the annual view, debt-to-equity went from 0.02 (FY22) to 0.02 (FY26). The returns on this page are earned, not borrowed.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Foreign institutions cut 1.0 points of Veedol Corporation Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 1.0% of the company. Promoters moved +0.4 points over the same window, to 64.6%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Foreign institutions: −1.0 points over 8 quarters to 1.0%; Promoters: +0.4 points over 8 quarters to 64.6%; Domestic institutions: −0.1 points over 8 quarters to 1.2%.
🚨 Why the register moved: foreign institutions drove it (−1.0 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Veedol Corporation Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Castrol India LtdCASTROLIND | 62.0/100Mixed-positive evidence97% evidence | TURNING | 25.8/35 Revenue 11.8% · PAT 11.3% · OPM change 3 pp 100% evidence | 22.0/25 ROCE 60.3% · OPM 26% 100% evidence | 8.8/20 P/E 17.2× · PEG 2.25 85% evidence | 5.4/20 RS sector -7.4% · RS bench 1.4% · 1Y -4.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 25.8 + 22 + 8.8 + 5.4 = 62 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -7.4% and the one-year return is -4.9%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 2Veedol Corporation Ltdthis pageVEEDOL | 60.4/100Mixed-positive evidence97% evidence | TURNING | 25.7/35 Revenue 12.9% · PAT 20.9% · OPM change 5 pp 100% evidence | 18.9/25 ROCE 24.1% · OPM 16% 100% evidence | 14.7/20 P/E 11.3× · PEG 1.4 85% evidence | 1.1/20 RS sector -13.2% · RS bench -5.2% · 1Y -12.1%1 of 12 weeks ahead 100% evidence |
| Exact sum: 25.7 + 18.9 + 14.7 + 1.1 = 60.4 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -13.2% and the one-year return is -12.1%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 3Gulf Oil Lubricants India LtdGULFOILLUB | 48.8/100Mixed-negative evidence91% evidence | BREAKING OUT | 14.7/35 Revenue 16.4% · PAT 0.8% · OPM change -1 pp 100% evidence | 17.9/25 ROCE 25.9% · OPM 12% 100% evidence | 11.2/20 P/E 13.5× · PEG 1.54 85% evidence | 5.0/20 RS sector -7.9% · RS bench -1% · 1Y -15.3%8 of 10 weeks ahead 70% evidence |
| Exact sum: 14.7 + 17.9 + 11.2 + 5 = 48.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4GOCL Corporation LtdGOCLCORP | 43.5/100Mixed-negative evidence78% evidence | BREAKING OUT | 10.4/35 Revenue -28.6% · PAT -74.8% · OPM change 55 pp 95% evidence | 4.4/25 ROCE 7% · OPM -122% 95% evidence | 13.0/20 P/E 8.2× · PEG — 35% evidence | 15.7/20 RS sector 3.6% · RS bench 33.8% · 1Y 22.8%9 of 11 weeks ahead 70% evidence |
| Exact sum: 10.4 + 4.4 + 13 + 15.7 = 43.5 · Decision use: Price leads the evidence: RS versus the benchmark is 33.8%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Veedol Corporation Ltd's share price today?
Veedol Corporation Ltd trades at ₹1,429, −20.0% over the past year. The company is valued at ₹2,489 Cr. The stock sits at 31% of its 52-week range of ₹1,281–₹1,760, −4.0% versus its 200-day average. On the tape, the price is in a downtrend, 38 weeks in. — as of 11 September 2026.
What were Veedol Corporation Ltd's latest quarterly results?
Veedol Corporation Ltd reported revenue of ₹609 Cr and net profit of ₹78.0 Cr for the Jun 26 quarter. Revenue rose 18.5% and profit rose 56.0% year on year. Earnings per share were ₹44.72. The operating margin was 16.0%, 5.0 pp higher than a year earlier. — as of 11 September 2026.
What is Veedol Corporation Ltd's revenue?
Veedol Corporation Ltd reported revenue of ₹609 Cr in the Jun 26 quarter, +18.5% year on year. For the full FY26 fiscal year, revenue was ₹2,169 Cr (+10.0%). Over the last 10 years revenue compounded at 8.3% a year. — as of 11 September 2026.
What is Veedol Corporation Ltd's profit?
Veedol Corporation Ltd earned ₹78.0 Cr of net profit in the Jun 26 quarter, +56.0% year on year. Full-year FY26 profit was ₹192 Cr. The operating margin ran 16.0% in the latest quarter. — as of 11 September 2026.
What is Veedol Corporation Ltd's market cap?
Veedol Corporation Ltd's market capitalisation is ₹2,489 Cr at a share price of ₹1,429. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is Veedol Corporation Ltd's P/E ratio?
Veedol Corporation Ltd trades at a P/E of 11.3×, at the 3rd percentile of its own 11-year range, against a long-run median of 17.3×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does Veedol Corporation Ltd pay a dividend?
Yes — Veedol Corporation Ltd's dividend payout was 103% of profit in FY26, and it recorded a payout in each of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.
Is Veedol Corporation Ltd overvalued?
On its own history, Veedol Corporation Ltd looks cheap: its P/E of 11.3× has been cheaper only 3% of the time in 11 years (long-run median 17.3×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.
Is Veedol Corporation Ltd growing?
Yes — Veedol Corporation Ltd is growing: latest-quarter revenue +18.5% year on year, profit +56.0%, and the margin +5.0 pp at 16.0%. The 10-year compound rates are 8.3% (revenue) and 8.4% (profit). The earnings engine currently reads: improving — as of 11 September 2026.
How is Veedol Corporation Ltd performing?
Veedol Corporation Ltd is in a downtrend, 38 weeks in. Its latest quarter's revenue rose 18.5% and profit rose 56.0% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 2 weeks. This describes what the data did, not a rating. — as of 11 September 2026.
What stage is Veedol Corporation Ltd in?
Consistent — revenue, profit and EPS growth have stayed positive through the window, with ROCE at 23.4% and holding. The read comes from the last 12 quarters of growth (revenue growth +12.9% latest, profit growth +20.9% latest, eps growth +21.3% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.
Is Veedol Corporation Ltd in an uptrend?
No — the price is in a downtrend (week 38 of stage 4), trading −4.0% versus its 200-day average and at 31% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is Veedol Corporation Ltd beating the market?
Not lately — on a trailing-13-week view Veedol Corporation Ltd is currently behind the NIFTY 500 (2 weeks and counting; last ahead the week of 2026-08-28), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved −1% against the NIFTY 500's +267% — behind the index over the full window. — as of 11 September 2026.
Will Veedol Corporation Ltd's share price go up?
This page publishes no price forecast for Veedol Corporation Ltd. What it measures instead: the share price is ₹1,429, the price is in a downtrend 38 weeks in. Its P/E of 11.3× sits at the 3rd percentile of its own 11-year range. — as of 11 September 2026.
Who owns Veedol Corporation Ltd?
Promoters hold 64.6% of Veedol Corporation Ltd, foreign institutions 1.0%, domestic institutions 1.2% and the public 30.8% (latest quarter). The biggest move on the register over the last two years: Foreign institutions cut 1.0 points over 8 quarters. — as of 11 September 2026.
Does Veedol Corporation Ltd have too much debt?
No — Veedol Corporation Ltd's debt-to-equity is 0.02, and operating profit covers the interest bill north of 100×. FY26 borrowings were ₹16.0 Cr against equity of ₹1,035 Cr. The returns on this page are earned, not borrowed — as of 11 September 2026.
What is Veedol Corporation Ltd's capex?
Veedol Corporation Ltd spent ₹163 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹46.0 Cr, with ₹8.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.
What is Veedol Corporation Ltd's cash flow?
Veedol Corporation Ltd generated ₹194 Cr of operating cash flow in FY26 and ₹148 Cr of free cash flow after ₹46.0 Cr of capital spending. Reported profit that year was ₹192 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 11 September 2026.
Is Veedol Corporation Ltd's profit real cash?
Mostly — over the last 3 fiscal years, 75% of Veedol Corporation Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹194 Cr against reported profit of ₹192 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 11 September 2026.
Where is Veedol Corporation Ltd in its business cycle?
Veedol Corporation Ltd's FY26 operating margin was 10.0%, against a 13-year band of 8.0%–13.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 16.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What growth does Veedol Corporation Ltd's price assume?
At its price on 13 June 2026, Veedol Corporation Ltd was priced for profit growth of about 4.5% a year. Profit itself has compounded 8.4% a year over the past 10 years. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 11 September 2026.
What could break the Veedol Corporation Ltd story?
The sharpest disagreement: annual EPS moved +13.5% against a −20.0% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is Veedol Corporation Ltd a stock worth studying right now?
This is not investment advice. The machine read: Veedol Corporation Ltd's earnings have outrun its stock. EPS grew +13.5% in a year against a −20.0% price move. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!